CAS RN 1335106-03-0

IUPAC Namn: N-(5-{[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]sulfamoyl}-4-methyl-1,3-thiazol-2-yl)acetamide

Synonymer: N-(5-{[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]sulfamoyl}-4-methyl-1,3-thiazol-2-yl)acetamide

Molekylvikt (g/mol): 477.4

Molekylär sammansättning: C15H13F6N3O4S2

InChi Key: OZBSSKGBKHOLGA-UHFFFAOYSA-N

SMILES: CC(=O)NC1=NC(C)=C(S1)S(=O)(=O)NC1=CC=C(C=C1)C(O)(C(F)(F)F)C(F)(F)F

1 – 1 av 1 Resultat

MedChemExpress SR1001 is a selective RORα and RORγt inverse agonist with Kis 172 and 111 nM, respectively.

Molekylformel	C₁₅H₁₃F₆N₃O₄S₂
Rekommenderad förvaring	Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month
Formel vikt	477.4
Hållbarhet	Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month
Hälsofara 1	H302∣H319
Löslighetsinformation	DMSO : ≥ 39 mg/mL (81.69 mM)
Anteckningar om renhetsgrad	Research
Fysisk form	Powder
Kvalitet	Research
Färg	Off-White
CAS	1335106-03-0
LEDER	CC(NC1=NC(C)=C(S(=O)(NC2=CC=C(C(C(F)(F)F)(O)C(F)(F)F)C=C2)=O)S1)=O
Molekylvikt (g/mol)	477.4
Kemiskt namn eller material	SR1001
Procent renhet	99.0%
För användning med (applikation)	COVID-19-immunoregulation